therascreen EGFR RGQ PCR Kit (24), Reference Number REF 870121

FDA Device Recall #Z-2290-2020 — Class II — April 8, 2020

Recall Summary

Recall Number Z-2290-2020
Classification Class II — Moderate risk
Date Initiated April 8, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Qiagen Sciences LLC
Location Germantown, MD
Product Type Devices
Quantity 530 kits within expiry

Product Description

therascreen EGFR RGQ PCR Kit (24), Reference Number REF 870121

Reason for Recall

There is a risk for a false mutation positive result in rare cases resulting from a fluorescence artefact. In these rare cases, the controls pass correctly, while a fluorescence artefact in the mutation assay causes an incorrect valid mutation positive result.

Distribution Pattern

US Nationwide.

Lot / Code Information

All lots

Other Recalls from Qiagen Sciences LLC

Recall # Classification Product Date
Z-1504-2025 Class II Brand Name: QIAstat-Dx Product Name: QIAstat-D... Mar 12, 2025
Z-2353-2024 Class II QIAcube Connect MDx - IVD Instrument designed t... Jun 3, 2024
Z-1508-2024 Class II EZ2 Connect MDx-IVD Designed to perform automat... Mar 4, 2024
Z-1683-2023 Class II QIAstat-Dx Respiratory SARS-CoV-2 Panel multipl... Apr 28, 2023
Z-1651-2022 Class II therascreen FGFR RGQ RT-PCR Kit (CE IVD, not so... Jul 20, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.